2025 Esmo Tat. 2024 Esmo Tat Britte Nickie Elena Garralda Cabanas, Cristian Massacesi, M.D., and Anastasios Stathis, Prof MD led the session, introducing key discussions on early-phase clinical trials and drug development. The ESMO TAT 2025 programme is online! Access the online programme The development of novel anticancer agents can transform our understanding of malignancies and impact clinical care
Beacon Checkpoint ESMO Congress 2023 Abstracts from beacon-intelligence.com
The ESMO TAT 2025 programme is online! Access the online programme The development of novel anticancer agents can transform our understanding of malignancies and impact clinical care The ESMO Targeted Anticancer Therapies Congress 2025 took place from 3 to 5 March 2025 in Paris, France
Beacon Checkpoint ESMO Congress 2023 Abstracts
The ESMO Colloquia are innovative sessions within the Congress programme that bring together top experts to discuss evolving areas of interest to the oncology community. Welcome to the ESMO TAT Congress 2025 by the Scientific Co-Chairs The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.ESMO TAT 2025 is a multi-stakeholder forum in the early drug development arena, which bring together investigators from academia, translational scientists.
ESMO Poster. The ESMO TAT 2025 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities: Proffered Paper - Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives. The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.ESMO TAT 2025 is a multi-stakeholder forum in the early drug development arena, which bring together investigators from academia, translational scientists.
ESMO Plenary Feb 2023 Pembrolizumab (pembro) plus chemotherapy (chemo) as firstline therapy. Welcome to the ESMO TAT Congress 2025 by the Scientific Co-Chairs The ESMO TAT Congress is dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical.